| Revenue | 21,833a | 21,067a | 22,299a |
| Costs of revenue | -16,455a | -16,096a | -17,241a |
| Gross profit | 5,378a | 4,971a | 5,058a |
| Selling expenses | -697a | -742a | -750a |
| General and administrative expenses | -2,222a | -2,285a | -2,405a |
| Other operating income | 293a | 417a | 402a |
| Other operating expenses | -329a | -517a | -501a |
| Research and development expenses | -641a | -661a | |
| Operating income (EBIT) | 1,782a | 1,183a | 1,143a |
| Income from investments accounted for using the equity method | 38a | -12a | |
| Interest income | 115a | 121a | 118a |
| Interest expenses | -547a | -519a | -534a |
| Income before income taxes | 1,388a | 773a | 715a |
| Income taxes | -521a | -485a | -477a |
| Net income from continuing operations | 867a | 288a | 238a |
| Noncontrolling interests in continuing operations | -34a | -110a | -115a |
| Net income from continuing operations attributable to shareholders of Fresenius SE & Co. KGaA | 901a | 398a | 353a |
| Net income from deconsolidated Fresenius Medical Care operations under IFRS 5 | | -1,938a | |
| Noncontrolling interests in deconsolidated Fresenius Medical Care operations under IFRS 5 | | -991a | |
| Net income from deconsolidated Fresenius Medical Care operations under IFRS 5 attributable to shareholders of Fresenius SE & Co. KGaA | | -947a | |
| Net income from discontinued operations | -571a | -50a | |
| Noncontrolling interests from discontinued operations | -141a | -5a | |
| Net income from discontinued operations attributable to shareholders of Fresenius SE & Co. KGaA | -430a | -45a | |
| Net income | 296a | -1,700a | |
| Noncontrolling interests in net income | -175a | -1,106a | |
| Net income attributable to shareholders of Fresenius SE & Co. KGaA | 471a | -594a | |